UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identification of Two Serine Residues Involved in Agonist Activation of the β-Adrenergic Receptor

The Journal of biological chemistry, 1989-08, Vol.264 (23), p.13572-13578

1989

Volltextzugriff (PDF)

Identification of Residues Required for Ligand Binding to the β -adrenergic Receptor

Proceedings of the National Academy of Sciences - PNAS, 1987-07, Vol.84 (13), p.4384-4388

1987

Volltextzugriff (PDF)

Structural features required for ligand binding to the beta‐adrenergic receptor

The EMBO journal, 1987-11, Vol.6 (11), p.3269-3275

1987

Volltextzugriff (PDF)

Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity

The Journal of biological chemistry, 1987-12, Vol.262 (34), p.16439-16443

1987

Volltextzugriff (PDF)

Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function

The Journal of biological chemistry, 1988-07, Vol.263 (21), p.10267-10271

1988

Volltextzugriff (PDF)

Mutational analysis of beta-adrenergic receptor glycosylation

The Journal of biological chemistry, 1990-06, Vol.265 (18), p.10759-10764

1990

Volltextzugriff (PDF)

Acute effect of ephedrine on 24-h energy balance

Clinical science (1979), 1999-05, Vol.96 (5), p.483

1999

Volltextzugriff (PDF)

A Single Amino Acid Substitution in the β-Adrenergic Receptor Promotes Partial Agonist Activity from Antagonists

The Journal of biological chemistry, 1989-10, Vol.264 (28), p.16470-16477

1989

Volltextzugriff (PDF)

Allele-specific activation of genetically engineered receptors

The Journal of biological chemistry, 1991-01, Vol.266 (1), p.5-8

1991

Volltextzugriff (PDF)

Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression

Endocrinology (Philadelphia), 1998-12, Vol.139 (12), p.4920-4927

1998

Volltextzugriff (PDF)

Ligand binding to the β -adrenergic receptor involves its rhodopsin-like core

Nature (London), 1987-03, Vol.326 (6108), p.73-77

1987

Volltextzugriff (PDF)

Potent and selective human beta(3)-adrenergic receptor antagonists

The Journal of pharmacology and experimental therapeutics, 1999-08, Vol.290 (2), p.649

1999

Volltextzugriff (PDF)

Nonpeptidal peptidomimetics with .beta.-D-glucose scaffolding. A partial somatostatin agonist bearing a close structural relationship to a potent, selective substance P antagonist

Journal of the American Chemical Society, 1992-11, Vol.114 (23), p.9217-9218

1992

Volltextzugriff (PDF)

The carboxyl terminus of the hamster β-adrenergic receptor expressed in mouse L cells is not required for receptor sequestration

Cell, 1987-06, Vol.49 (6), p.855-863

1987

Volltextzugriff (PDF)

Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide

Journal of medicinal chemistry, 2000-10, Vol.43 (21), p.3832-3836

2000

Volltextzugriff (PDF)

Pharmacological characterization of a recently described human beta 3-adrenergic receptor mutant

Endocrinology (Philadelphia), 1996-06, Vol.137 (6), p.2638-2641

1996

Volltextzugriff (PDF)

Substituted oxazole benzenesulfonamides as potent human β3 adrenergic receptor agonists

Bioorganic & medicinal chemistry letters, 2000-07, Vol.10 (14), p.1531-1534

2000

Volltextzugriff (PDF)

Beta-adrenergic receptor subtype is an intrinsic property of the receptor gene product

Molecular pharmacology, 1987-08, Vol.32 (1), p.179-183

1987

Volltextzugriff (PDF)

Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptor

The Journal of pharmacology and experimental therapeutics, 1998-11, Vol.287 (2), p.720

1998

Volltextzugriff (PDF)

A Novel Glucagon Receptor Antagonist Inhibits Glucagon-Mediated Biological Effects

Diabetes (New York, N.Y.), 2004-12, Vol.53 (12), p.3267-3273

2004

Volltextzugriff (PDF)

Genetic analysis of the molecular basis for β-adrenergic receptor subtype specificity

Proteins, structure, function, and bioinformatics, 1989, Vol.6 (3), p.267-274

1989

Volltextzugriff (PDF)

Human β 3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Bioorganic & medicinal chemistry letters, 2000-09, Vol.10 (18), p.2111-2114

2000

Volltextzugriff (PDF)

Discovery of a Potent, Orally Bioavailable β3 Adrenergic Receptor Agonist, (R)-N-[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide

Journal of medicinal chemistry, 2000-10, Vol.43 (21), p.3832-3836

2000

Volltextzugriff (PDF)

Molecular approaches to the discovery of new treatments for obesity

Current opinion in chemical biology, 1997-08, Vol.1 (2), p.204-209

1997

Volltextzugriff (PDF)

Biophysical and genetic analysis of the ligand-binding site of the β-adrenoceptor

Trends in pharmacological sciences (Regular ed.), 1991, Vol.12 (1), p.4-6

1991

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(80)

Sprache

Englisch
(80)
Japanisch
(14)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Identification of Two Serine Residues Involved in Agonist Activation of the β-Adrenergic Receptor

Identification of Residues Required for Ligand Binding to the β -adrenergic Receptor

Structural features required for ligand binding to the beta‐adrenergic receptor

Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity

Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function

Mutational analysis of beta-adrenergic receptor glycosylation

Acute effect of ephedrine on 24-h energy balance

A Single Amino Acid Substitution in the β-Adrenergic Receptor Promotes Partial Agonist Activity from Antagonists

Allele-specific activation of genetically engineered receptors

Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression

Ligand binding to the β -adrenergic receptor involves its rhodopsin-like core

Potent and selective human beta(3)-adrenergic receptor antagonists

Nonpeptidal peptidomimetics with .beta.-D-glucose scaffolding. A partial somatostatin agonist bearing a close structural relationship to a potent, selective substance P antagonist

The carboxyl terminus of the hamster β-adrenergic receptor expressed in mouse L cells is not required for receptor sequestration

Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide

Pharmacological characterization of a recently described human beta 3-adrenergic receptor mutant

Substituted oxazole benzenesulfonamides as potent human β3 adrenergic receptor agonists

Beta-adrenergic receptor subtype is an intrinsic property of the receptor gene product

Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptor

A Novel Glucagon Receptor Antagonist Inhibits Glucagon-Mediated Biological Effects

Genetic analysis of the molecular basis for β-adrenergic receptor subtype specificity

Human β 3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Discovery of a Potent, Orally Bioavailable β3 Adrenergic Receptor Agonist, (R)-N-[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide

Molecular approaches to the discovery of new treatments for obesity

Biophysical and genetic analysis of the ligand-binding site of the β-adrenoceptor

Suchergebnisse filtern